Physician profile
Frederick Rutkovsky
NPI 1477651123
$1,285.17
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $145 · 2021: $295 · 2022: $468.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.46 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $181.92 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.08 | 2021-2022 | |
| Novo Nordisk INC | $119.18 | 2019-2022 | |
| Amarin Pharma, INC. | $82.89 | 2019-2020 | |
| Gilead Sciences, INC. | $77.68 | 2019-2020 | |
| Amgen INC. | $66.34 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $56.80 | 2021-2022 | |
| Abbott Laboratories | $51.51 | 2019-2022 | |
| Boston Scientific Corporation | $49.86 | 2019-2022 | |
| Dynavax Technologies Corporation | $38.37 | 2021 | |
| Redhill Biopharma INC. | $33.59 | 2021-2022 | |
| Pfizer INC. | $32.32 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $30.10 | 2019-2020 | |
| Sanofi Pasteur INC. | $24.45 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $23.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.52 | 2021 | |
| Qol Medical, LLC | $19.82 | 2019 | |
| Edwards Lifesciences Corporation | $17.99 | 2020 | |
| Esperion Therapeutics, INC. | $17.33 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Rutkovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.